Talphera (TLPH) Return on Capital Employed Growth (1y) (2013 - 2026)
Talphera (TLPH) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 1,195.00 |
| 10 | Talphera | 90.77 Mn | 90.77 Mn | - | 3,922.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,922.00 |
| Dec 31, 2025 | 3,880.00 |
| Sep 30, 2025 | 1,818.00 |
| Jun 30, 2025 | -3,335.00 |
| Mar 31, 2025 | -2,086.00 |
| Dec 31, 2024 | -2,186.00 |
| Sep 30, 2024 | -294.00 |
| Jun 30, 2024 | 1,362.00 |
| Mar 31, 2024 | 63.00 |
| Dec 31, 2023 | 1,805.00 |
| Sep 30, 2023 | 749.00 |
| Jun 30, 2023 | -488.00 |
| Mar 31, 2023 | -1,315.00 |
| Dec 31, 2022 | -2,245.00 |
| Sep 30, 2022 | -2,361.00 |
| Jun 30, 2022 | -2,229.00 |
| Mar 31, 2022 | -596.00 |
| Dec 31, 2021 | 2,071.00 |
| Sep 30, 2021 | 3,007.00 |
| Jun 30, 2021 | 3,671.00 |